<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Drug Topics articles</title><description>Drug Topics articles</description><link>https://www.drugtopics.com/news</link><category>Drug Topics articles</category><copyright>© 2026 MJH Life Sciences™ and Drug Topics. All rights reserved.</copyright><lastBuildDate>Sat, 17 Oct 2026 22:50:22 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.drugtopics.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Drug Topics articles</title><width>144</width><height>47</height><link>https://www.drugtopics.com/news</link><url>https://www.drugtopics.com/logo.webp</url></image><item><title>&lt;![CDATA[FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026]]&gt;</title><link>https://www.drugtopics.com/view/scaling-pharmacy-services-through-glp-1-care-ncpa-2026</link><guid isPermaLink="true">https://www.drugtopics.com/view/scaling-pharmacy-services-through-glp-1-care-ncpa-2026</guid><description>&lt;![CDATA[Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.]]&gt;</description><pubDate>Sat, 17 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026]]&gt;</title><link>https://www.drugtopics.com/view/pharmacists-must-guide-peptide-talks-pending-fda-action-ncpa-2026</link><guid isPermaLink="true">https://www.drugtopics.com/view/pharmacists-must-guide-peptide-talks-pending-fda-action-ncpa-2026</guid><description>&lt;![CDATA[Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.]]&gt;</description><pubDate>Fri, 16 Oct 2026 17:50:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FDA Approves Brytly for OTC Eye Redness Relief]]&gt;</title><link>https://www.drugtopics.com/view/fda-approves-brytly-for-otc-eye-redness-relief</link><guid isPermaLink="true">https://www.drugtopics.com/view/fda-approves-brytly-for-otc-eye-redness-relief</guid><description>&lt;![CDATA[This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.]]&gt;</description><pubDate>Fri, 16 Oct 2026 16:10:33 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[American Pharmacists Month: Why It Matters More Than Ever]]&gt;</title><link>https://www.drugtopics.com/view/why-american-pharmacists-month-matters-more-than-ever</link><guid isPermaLink="true">https://www.drugtopics.com/view/why-american-pharmacists-month-matters-more-than-ever</guid><description>&lt;![CDATA[Cheri Schmit explains how pharmacists&apos; roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.]]&gt;</description><pubDate>Fri, 16 Oct 2026 14:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[American Pharmacists Month: Celebrating the Pharmacist’s Community Role]]&gt;</title><link>https://www.drugtopics.com/view/american-pharmacists-month-celebrating-the-pharmacist-s-community-role</link><guid isPermaLink="true">https://www.drugtopics.com/view/american-pharmacists-month-celebrating-the-pharmacist-s-community-role</guid><description>&lt;![CDATA[In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.]]&gt;</description><pubDate>Thu, 15 Oct 2026 18:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[OTC: Back-to-School Health]]&gt;</title><link>https://www.drugtopics.com/view/otc-back-to-school-health</link><guid isPermaLink="true">https://www.drugtopics.com/view/otc-back-to-school-health</guid><description>&lt;![CDATA[Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.]]&gt;</description><pubDate>Thu, 15 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Q&amp;A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026]]&gt;</title><link>https://www.drugtopics.com/view/emerging-compounded-therapies-demand-pharmacist-s-clinical-judgment-ncpa-2026</link><guid isPermaLink="true">https://www.drugtopics.com/view/emerging-compounded-therapies-demand-pharmacist-s-clinical-judgment-ncpa-2026</guid><description>&lt;![CDATA[Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.]]&gt;</description><pubDate>Thu, 15 Oct 2026 14:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Is Your Independent Pharmacy Ready for New Therapies and Innovations?]]&gt;</title><link>https://www.drugtopics.com/view/is-your-independent-pharmacy-ready-for-new-therapies-and-innovations-</link><guid isPermaLink="true">https://www.drugtopics.com/view/is-your-independent-pharmacy-ready-for-new-therapies-and-innovations-</guid><description>&lt;![CDATA[Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.]]&gt;</description><pubDate>Wed, 14 Oct 2026 19:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Dispensing Leadership: Full Commitment Turns Ideas Into Real Impact]]&gt;</title><link>https://www.drugtopics.com/view/dispensing-leadership-full-commitment-turns-ideas-into-real-impact</link><guid isPermaLink="true">https://www.drugtopics.com/view/dispensing-leadership-full-commitment-turns-ideas-into-real-impact</guid><description>&lt;![CDATA[During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.]]&gt;</description><pubDate>Wed, 14 Oct 2026 17:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Wearable Tech as a Revenue, Clinical Service Opportunity for Pharmacists | NCPA 2026]]&gt;</title><link>https://www.drugtopics.com/view/wearable-tech-as-a-revenue-clinical-service-opportunity-for-pharmacists-ncpa-2026</link><guid isPermaLink="true">https://www.drugtopics.com/view/wearable-tech-as-a-revenue-clinical-service-opportunity-for-pharmacists-ncpa-2026</guid><description>&lt;![CDATA[Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.]]&gt;</description><pubDate>Wed, 14 Oct 2026 15:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Building Clinician Confidence to Prescribe HIV PrEP in Primary Care]]&gt;</title><link>https://www.drugtopics.com/view/building-clinician-confidence-to-prescribe-hiv-prep-in-primary-care</link><guid isPermaLink="true">https://www.drugtopics.com/view/building-clinician-confidence-to-prescribe-hiv-prep-in-primary-care</guid><description>&lt;![CDATA[Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach that build prescriber confidence, and explain why HIV prevention still matters in the treatment era.]]&gt;</description><pubDate>Wed, 14 Oct 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[PrEP Deserts: Why HIV Prevention Still Misses Those at Risk]]&gt;</title><link>https://www.drugtopics.com/view/prep-deserts-why-hiv-prevention-still-misses-those-at-risk</link><guid isPermaLink="true">https://www.drugtopics.com/view/prep-deserts-why-hiv-prevention-still-misses-those-at-risk</guid><description>&lt;![CDATA[A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit PrEP uptake. The faculty examine what sustains PrEP deserts and how to bridge them.]]&gt;</description><pubDate>Wed, 14 Oct 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Pharmacists Improve Access, Safe Use of Obesity Medications]]&gt;</title><link>https://www.drugtopics.com/view/pharmacists-improve-access-safe-use-of-obesity-medications</link><guid isPermaLink="true">https://www.drugtopics.com/view/pharmacists-improve-access-safe-use-of-obesity-medications</guid><description>&lt;![CDATA[Diabetes medication experts focus on practical access and pharmacist counseling considerations for adults on obesity medication.]]&gt;</description><pubDate>Tue, 13 Oct 2026 19:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FDA Approves New Drug for HSV Lesions in Adults]]&gt;</title><link>https://www.drugtopics.com/view/fda-approves-new-drug-for-hsv-lesions-in-adults</link><guid isPermaLink="true">https://www.drugtopics.com/view/fda-approves-new-drug-for-hsv-lesions-in-adults</guid><description>&lt;![CDATA[The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.]]&gt;</description><pubDate>Tue, 13 Oct 2026 16:00:05 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[American Pharmacists Month: Community Pharmacies Becoming Care Providers]]&gt;</title><link>https://www.drugtopics.com/view/american-pharmacists-month-community-pharmacies-becoming-care-providers</link><guid isPermaLink="true">https://www.drugtopics.com/view/american-pharmacists-month-community-pharmacies-becoming-care-providers</guid><description>&lt;![CDATA[Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.]]&gt;</description><pubDate>Tue, 13 Oct 2026 15:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Every Visit Is a Chance to Care: How Pharmacy Teams Can Catch More Care Opportunities at the Counter]]&gt;</title><link>https://www.drugtopics.com/view/every-visit-is-a-chance-to-care-how-pharmacy-teams-can-catch-more-care-opportunities-at-the-counter</link><guid isPermaLink="true">https://www.drugtopics.com/view/every-visit-is-a-chance-to-care-how-pharmacy-teams-can-catch-more-care-opportunities-at-the-counter</guid><description>&lt;![CDATA[EQUIPP Copilot™ puts care opportunities in front of your team while the patient is still at the counter, in the pharmacy management system you already use.]]&gt;</description><pubDate>Tue, 13 Oct 2026 13:00:31 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FDA Approves Once-Monthly Olanzapine Injection for Adults with Schizophrenia]]&gt;</title><link>https://www.drugtopics.com/view/fda-approves-once-monthly-olanzapine-injection-for-adults-with-schizophrenia</link><guid isPermaLink="true">https://www.drugtopics.com/view/fda-approves-once-monthly-olanzapine-injection-for-adults-with-schizophrenia</guid><description>&lt;![CDATA[Teva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.]]&gt;</description><pubDate>Mon, 12 Oct 2026 19:08:02 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Indoor Air Sampling Could Revolutionize Pneumococcal Disease Surveillance]]&gt;</title><link>https://www.drugtopics.com/view/indoor-air-sampling-could-revolutionize-pneumococcal-disease-surveillance</link><guid isPermaLink="true">https://www.drugtopics.com/view/indoor-air-sampling-could-revolutionize-pneumococcal-disease-surveillance</guid><description>&lt;![CDATA[The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.]]&gt;</description><pubDate>Mon, 12 Oct 2026 17:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[American Pharmacists Month: The Many Career Paths US Pharmacists Explore]]&gt;</title><link>https://www.drugtopics.com/view/american-pharmacists-month-the-many-career-paths-us-pharmacists-explore</link><guid isPermaLink="true">https://www.drugtopics.com/view/american-pharmacists-month-the-many-career-paths-us-pharmacists-explore</guid><description>&lt;![CDATA[Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.]]&gt;</description><pubDate>Mon, 12 Oct 2026 15:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Community-Based Equity Strategies Best for Improving Vaccine Uptake]]&gt;</title><link>https://www.drugtopics.com/view/community-based-equity-strategies-best-for-improving-vaccine-uptake</link><guid isPermaLink="true">https://www.drugtopics.com/view/community-based-equity-strategies-best-for-improving-vaccine-uptake</guid><description>&lt;![CDATA[Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.]]&gt;</description><pubDate>Sun, 11 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[From Binder to Action: Making Infectious Disease Outbreak Plans Operational]]&gt;</title><link>https://www.drugtopics.com/view/from-binder-to-action-making-infectious-disease-outbreak-plans-operational</link><guid isPermaLink="true">https://www.drugtopics.com/view/from-binder-to-action-making-infectious-disease-outbreak-plans-operational</guid><description>&lt;![CDATA[Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.]]&gt;</description><pubDate>Sat, 10 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Pharmacist Pain Management Clinics: The Expert as the Pain Coach]]&gt;</title><link>https://www.drugtopics.com/view/pharmacist-pain-management-clinics-the-expert-as-the-pain-coach</link><guid isPermaLink="true">https://www.drugtopics.com/view/pharmacist-pain-management-clinics-the-expert-as-the-pain-coach</guid><description>&lt;![CDATA[Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.]]&gt;</description><pubDate>Fri, 09 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Serotype 34 Causes Pneumococcal Meningitis in Child With Cochlear Implants]]&gt;</title><link>https://www.drugtopics.com/view/serotype-34-causes-pneumococcal-meningitis-in-child-with-cochlear-implants</link><guid isPermaLink="true">https://www.drugtopics.com/view/serotype-34-causes-pneumococcal-meningitis-in-child-with-cochlear-implants</guid><description>&lt;![CDATA[A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.]]&gt;</description><pubDate>Fri, 09 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes]]&gt;</title><link>https://www.drugtopics.com/view/retatrutide-delivers-20-8-weight-loss-in-adults-with-type-2-diabetes</link><guid isPermaLink="true">https://www.drugtopics.com/view/retatrutide-delivers-20-8-weight-loss-in-adults-with-type-2-diabetes</guid><description>&lt;![CDATA[Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.]]&gt;</description><pubDate>Fri, 09 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Independent Pharmacies Remain Resilient, Essential Community Providers | NCPA 2026]]&gt;</title><link>https://www.drugtopics.com/view/independent-pharmacies-remain-resilient-essential-community-providers-ncpa-2026</link><guid isPermaLink="true">https://www.drugtopics.com/view/independent-pharmacies-remain-resilient-essential-community-providers-ncpa-2026</guid><description>&lt;![CDATA[In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.]]&gt;</description><pubDate>Fri, 09 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Community Pharmacy Partnerships That Close the Gaps]]&gt;</title><link>https://www.drugtopics.com/view/community-pharmacy-partnerships-that-close-the-gaps</link><guid isPermaLink="true">https://www.drugtopics.com/view/community-pharmacy-partnerships-that-close-the-gaps</guid><description>&lt;![CDATA[Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.]]&gt;</description><pubDate>Thu, 08 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Integrated Care and the Keys to Successful GLP-1 Therapy]]&gt;</title><link>https://www.drugtopics.com/view/integrated-care-and-the-keys-to-successful-glp-1-therapy</link><guid isPermaLink="true">https://www.drugtopics.com/view/integrated-care-and-the-keys-to-successful-glp-1-therapy</guid><description>&lt;![CDATA[In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.]]&gt;</description><pubDate>Thu, 08 Oct 2026 18:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration]]&gt;</title><link>https://www.drugtopics.com/view/pharmacist-protocol-is-linked-with-more-same-day-vaccine-coadministration</link><guid isPermaLink="true">https://www.drugtopics.com/view/pharmacist-protocol-is-linked-with-more-same-day-vaccine-coadministration</guid><description>&lt;![CDATA[A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.]]&gt;</description><pubDate>Thu, 08 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms]]&gt;</title><link>https://www.drugtopics.com/view/policies-for-pharmacists-to-track-heading-into-2026-midterms</link><guid isPermaLink="true">https://www.drugtopics.com/view/policies-for-pharmacists-to-track-heading-into-2026-midterms</guid><description>&lt;![CDATA[In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more. ]]&gt;</description><pubDate>Thu, 08 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Addressing Medication Adherence in Cardiometabolic Health]]&gt;</title><link>https://www.drugtopics.com/view/addressing-medication-adherence-in-cardiometabolic-health</link><guid isPermaLink="true">https://www.drugtopics.com/view/addressing-medication-adherence-in-cardiometabolic-health</guid><description>&lt;![CDATA[Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.]]&gt;</description><pubDate>Wed, 07 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item></channel></rss>